Rentokil shares fall after third warning on North America weakness
Shares have lost about a third in value since October 2023
Company to cut US jobs to address cost overruns
Says North America sales in July and August lower than expected
Adds CEO comment in paragraph 3, details on Terminix deal and analyst quote in paragraphs 10-12
By Yamini Kalia and Yadarisa Shabong
Sept 11 (Reuters) -Rentokil Initial RTO.L warned of lower annual profit on Wednesday after weaker than expected sales in its largest market North America, sending shares of the British pest control company as much as 20% down.
This is the third warning about weakness in its North America business in the past year.
In a conference call with analysts and investors, CEO Andy Ransom expressed disappointment in the execution of the group's strategy, launched in March, to improve revenue growth. He, however, added that he had confidence in the plan and would not change it.
The company's shares, which have lost about a third of their value since the first North America warning in October last year, were down 20% to 380 pence at 0800 GMT. The stock was the biggest loser on the FTSE 100 index .FTSE.
Rentokil, which made about 60% of its revenue in North America last year, said it would cut an undisclosed number of jobs in its U.S. workforce to address cost overruns.
Rentokil now expects full-year adjusted pretax profit to be about 700 million pounds ($916 million), versus the 766 million pounds it reported last year.
Analysts at RBC Capital Markets had expected pretax profit of about 777 million pounds.
North America sales in July and August came in lower than anticipated, organic revenue growth is now expected to grow about 1% in the second half.
The company had previously expected revenue growth to be at the lower end of a 2-4% growth range.
Rentokil, which bought U.S rival Terminixin 2021, has been struggling to integrate its business and said on Wednesday it saw a modest disruption to organic growth from the deal.
About 5.4 billion pounds have been wiped from the pest control company's market capitalisation since it issued its first profit warning in October 2023.
"The profit warning will raise further questions on management control and visibility in the region," Jefferies' analyst Allen Wells said in a note.
The company has also increased its spending on marketing in a bid to attract more customers in North America.
Activist investor Nelson Peltz's Trian Fund Management has built a stake in the company and in June said it was interested in discussing "ideas and initiatives".
Rentokil and rival Rollins account for roughly half of the U.S. pest control market, with Rentokil the larger player following the Terminix deal.
($1 = 0.7642 pounds)
Reporting by Shanima A, Yamini Kalia and Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips and Mark Potter
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
